Capstone Investment Advisors »

Cytokinetics shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 154k 83.49
2023-09-30 $1.1M 39k 29.46
2020-12-31 $727k 35k 20.77

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Select Sector Spdr Tr Financial Call Option (XLF)
Broadcom Call Option (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics